Table 2

Prevalences of sitting and TV viewing at baseline in the prospective cohort studies included in the meta-analysis

StudyPrevalences
Sitting time
 Katzmarzyk et al15 (Canada Fitness Survey)None/¼ time½ Time¾ Time/all
Source prevalence (%)*56.925.717.4
Case prevalence (%)45.129.625.3
Case:source ratio0.791.151.45
 Patel et al16 (Cancer Prevention Study II Nutrition Cohort)<3 h3–5 h≥6 h
Source prevalence (%)*46.243.110.7
Case prevalence (%)36.847.815.4
Case:source ratio0.801.111.44
Average case:source ratio0.801.111.44
TV viewing
 Dunstan et al17 (Australian Diabetes, Obesity and Lifestyle Study (AusDiab))<2 h2–3.9 h≥4 h
Source prevalence (%)*56.535.97.6
Case prevalence (%)37.044.019.0
Case:source ratio0.651.232.50
 Stamatakis et al18 (Scottish Health Survey)<2 h2–3.9 h≥4 h
Source prevalence (%)*17.154.128.8
Case prevalence (%)13.445.241.4
Case:source ratio0.780.841.44
 Wijndaele et al19 (EPIC—Norfolk Study)<2.5 h2.5–3.6 h>3.6 h
Source prevalence (%)*33.333.832.9
Case prevalence (%)22.932.644.5
Case:source ratio0.690.961.35
Average case:source ratio0.691.031.75
  • * Prevalences of sitting or TV viewing in the source population at baseline.

  • Prevalences of sitting or TV viewing in cases (decedents) at baseline.

  • Weighted average case:source prevalence ratio from the prospective cohort studies.

  • TV, television.